These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 14519886)

  • 1. Peptide-treated stent graft for the treatment of saphenous vein graft lesions: first clinical results.
    Hamm CW; Schäachinger V; Münzel T; Maikowski C; Bonzel T; Köster R; Rau M; Zeiher AM
    J Invasive Cardiol; 2003 Oct; 15(10):557-60. PubMed ID: 14519886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of post-stenotic saphenous vein graft aneurysm: special considerations with the polytetrafluoroethylene-covered stent.
    Ho PC; Leung CY
    J Invasive Cardiol; 2004 Oct; 16(10):604-5. PubMed ID: 15505363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized evaluation of polytetrafluoroethylene-covered stent in saphenous vein grafts: the Randomized Evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts (RECOVERS) Trial.
    Stankovic G; Colombo A; Presbitero P; van den Branden F; Inglese L; Cernigliaro C; Niccoli L; Bartorelli AL; Rubartelli P; Reifart N; Heyndrickx GR; Saunamäki K; Morice MC; Sgura FA; Di Mario C;
    Circulation; 2003 Jul; 108(1):37-42. PubMed ID: 12821546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of the Symbiot PTFE-covered stent to reduce distal embolization during percutaneous coronary intervention in saphenous vein grafts.
    Blackman DJ; Choudhury RP; Banning AP; Channon KM
    J Invasive Cardiol; 2005 Nov; 17(11):609-12. PubMed ID: 16264208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility, safety, and preliminary efficacy of a novel ePTFE-covered self-expanding stent in saphenous vein graft lesions: the Symbiot II trial.
    Laarman GJ; Kiemeneij F; Mueller R; Guagliumi G; Cobaugh M; Serruys PW;
    Catheter Cardiovasc Interv; 2005 Mar; 64(3):361-8. PubMed ID: 15736242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era.
    Pucelikova T; Mehran R; Kirtane AJ; Kim YH; Fahy M; Weisz G; Lansky AJ; Moussa I; Gray WA; Collins MB; Kodali SK; Stone GW; Moses JW; Leon MB; Dangas G
    Am J Cardiol; 2008 Jan; 101(1):63-8. PubMed ID: 18157967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Saphenous vein graft disease treated with the Wiktor Hepamed stent: procedural outcome, in-hospital complications and six-month angiographic follow-up.
    Van Langenhove G; Vermeersch P; Serrano P; Kutryk MJ; Stockman D; Convens C; Van den Branden F; Vanagt E; Albertal M; Van den Heuvel P
    Can J Cardiol; 2000 Apr; 16(4):473-80. PubMed ID: 10787462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pivotal, randomized U.S. study of the Symbiottrade mark covered stent system in patients with saphenous vein graft disease: eight-month angiographic and clinical results from the Symbiot III trial.
    Turco MA; Buchbinder M; Popma JJ; Weissman NJ; Mann T; Doucet S; Johnson WL; Greenberg JD; Leadley K; Russell ME
    Catheter Cardiovasc Interv; 2006 Sep; 68(3):379-88. PubMed ID: 16892434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial.
    Vermeersch P; Agostoni P; Verheye S; Van den Heuvel P; Convens C; Bruining N; Van den Branden F; Van Langenhove G
    J Am Coll Cardiol; 2006 Dec; 48(12):2423-31. PubMed ID: 17174178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occlusion of the saphenous vein graft at the site of polytetrafluoroethylene membrane-covered stent implantation: was it late thrombosis?
    Toutouzas K; Takagi T; Colombo A
    J Invasive Cardiol; 2003 Dec; 15(12):722-4. PubMed ID: 14660828
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of percutaneous coronary interventions for in-stent restenosis in degenerated saphenous vein grafts without distal embolic protection.
    Ashby DT; Dangas G; Aymong EA; Iakovou I; Kuepper F; Mehran R; Stone GW; Leon MB; Moses JW
    J Am Coll Cardiol; 2003 Mar; 41(5):749-52. PubMed ID: 12628717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procedural results and distal embolization after saphenous vein graft stenting and angioplasty for in-stent restenosis of grafts.
    Cicek D; Doven O; Pekdemir H; Camsari A; Akkus NM; Cin GV; Parmaksiz T; Katircibasi T
    Jpn Heart J; 2004 Jul; 45(4):561-71. PubMed ID: 15353867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes of drug-eluting stents versus bare-metal stents in saphenous vein graft disease: results from the Prairie "Real World" Stent Registry.
    Goswami NJ; Gaffigan M; Berrio G; Plessa AL; Pfeiffer AM; Markwell SJ; Mishkel GJ
    Catheter Cardiovasc Interv; 2010 Jan; 75(1):93-100. PubMed ID: 19787803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contemporary use of embolic protection devices in saphenous vein graft interventions: Insights from the stenting of saphenous vein grafts trial.
    Badhey N; Lichtenwalter C; de Lemos JA; Roesle M; Obel O; Addo TA; Haagen D; Abdel-Karim AR; Saeed B; Bissett JK; Sachdeva R; Voudris VV; Karyofillis P; Kar B; Rossen J; Fasseas P; Berger PB; Banerjee S; Brilakis ES
    Catheter Cardiovasc Interv; 2010 Aug; 76(2):263-9. PubMed ID: 20665875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a self-expanding super-elastic all-metal endoprosthesis; to treat degenerated SVG lesions: the SESAME first in man trial.
    Abizaid A; Weiner B; Bailey SR; Londero H
    Catheter Cardiovasc Interv; 2010 Nov; 76(6):781-6. PubMed ID: 20549692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contemporary percutaneous treatment of saphenous vein graft stenosis: immediate and late outcomes.
    Nishida T; Colombo A; Briguori C; Adamian M; Finci L; Albiero R; Ferraro M; Di Mario C
    J Invasive Cardiol; 2000 Oct; 12(10):505-12. PubMed ID: 11022209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous intervention of acutely occluded saphenous vein grafts: contemporary techniques and outcomes.
    Abdel-Karim AR; Banerjee S; Brilakis ES
    J Invasive Cardiol; 2010 Jun; 22(6):253-7. PubMed ID: 20516502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous saphenous vein graft interventions with and without distal filter wire protection.
    Hofmann M; Störger H; Schwarz F; Schwarz CE; Reinemer H; Ruef J; Schöpf J; Haase J
    J Interv Cardiol; 2005 Dec; 18(6):475-9. PubMed ID: 16336428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic total occlusion treatment in post-CABG patients: saphenous vein graft versus native vessel recanalization-long-term follow-up in the drug-eluting stent era.
    Meliga E; García-García HM; Kukreja N; Daemen J; Tanimoto S; Ramcharitar S; van Mieghem CA; Sianos G; van der Ent M; van der Giessen WJ; de Feyter P; van Domburg R; Serruys PW
    Catheter Cardiovasc Interv; 2007 Jul; 70(1):21-5. PubMed ID: 17584913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Pharmacologic" distal protection using prophylactic, intragraft nicardipine to prevent no-reflow and non-Q-wave myocardial infarction during elective saphenous vein graft intervention.
    Fischell TA; Subraya RG; Ashraf K; Perry B; Haller S
    J Invasive Cardiol; 2007 Feb; 19(2):58-62. PubMed ID: 17268038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.